Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


& Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO


PR Newswire | Mar 12, 2021 10:50PM EST

& Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO

03/12 21:50 CST

INOVIO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO NEW ORLEANS, March 12, 2021

NEW ORLEANS, March 12, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Inovio Pharmaceuticals Inc. (NasdaqGS: INO).

On March 9, 2020 Citron Research published a statement highlighting the Company's "ludicrous and dangerous claim that they designed a [COVID-19] vaccine in 3 hours" and calling for an SEC investigation into the claims. That same day, the Company disclosed that its purported COVID-19 vaccine, which had been developed "within three hours," was not a fully-fledged vaccine at all, but merely a construct for a vaccine.

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws. Recently, the court in that case denied the Company's motion to dismiss in part, allowing the case to move forward.

KSF's investigation is focusing on whether Inovio's officers and/or directors breached their fiduciary duties to Inovio's shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Inovio shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-ino/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients - including public institutional investors, hedge funds, money managers and retail investors - in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact: Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com1-877-515-1850 1100 Poydras St., Suite 3200 New Orleans, LA 70163

View original content to download multimedia: http://www.prnewswire.com/news-releases/inovio-investigation-continued-by-former-louisiana-attorney-general--kahn-swick--foti-llc-continues-to-investigate-the-officers-and-directors-of-inovio-pharmaceuticals-inc--ino-301246219.html

SOURCE Kahn Swick & Foti, LLC






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC